Home>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Sulfamoxole

Sulfamoxole (Synonyms: NSC 683535)

Catalog No.GC45610

A sulfonamide antibiotic

Products are for research use only. Not for human use. We do not sell to patients.

Sulfamoxole Chemical Structure

Cas No.: 729-99-7

Size Price Stock Qty
25mg
$67.00
In stock
50mg
$121.00
In stock
100mg
$201.00
In stock
250mg
$369.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Sulfamoxole is a sulfonamide antibiotic.1 It is inactive or weakly active against bacteria when used alone but acts synergistically with trimethoprim against a variety of bacteria in vitro, including strains of S. pyogenes, E. coli, and P. vulgaris when used at concentrations of 1.95-7.8, 0.12-1.95, and 0.48-0.97 μg/ml, respectively. Sulfamoxole, in combination with trimethoprim, is effective in mouse models of E. coli or P. vulgaris infection. It inhibits P. carinii recombinant dihydropteroate synthase (DHPS), an enzyme required for the biosynthesis of folate, with an IC50 value of 0.089 μM.2

|1. B•hni, E. Bacteriostatic and bactericidal activity of two trimethoprim-sulfonamide combinations. Chemotherapy 22(3-4), 262-273 (1976).|2. Hong, Y.-L., Hossler, P.A., Calhoun, D.H., et al. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob. Agents Chemother. 39(8), 1756-1763 (1995).

Reviews

Review for Sulfamoxole

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sulfamoxole

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.